Quality of life concerns; living with MDS

Rena Buckstein, MD, FRCPC, Odette Cancer Research Program, Sunnybrook Research Institute, Toronto, Canada, discusses the quality of life (QoL) of patients with myelodysplastic syndromes, and the factors contributing to reductions and improvements in QoL. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Share this video  
Similar topics
Related videos
5th March 2020